Glaukos
Latest round
- Series F
Last raised
- Jan 2013
Total raised
- $145M
Investors
- 9
About Glaukos
Glaukos Corporation is a specialized company that develops innovative therapies for ophthalmic diseases.Glaukos Corporation specializes in the development and commercialization of innovative therapies for ophthalmic diseases, focusing on glaucoma, corneal health, and retinal conditions. Their core offerings include a portfolio of advanced glaucoma treatments such as the iStent® and iDose® TR, which aim to lower intraocular pressure in patients with open-angle glaucoma. Additionally, Glaukos provides cross-linking interventions, like the iLink system, designed to halt or slow the progression of keratoconus, preserving patients’ vision.73 mn. The company generates revenue primarily through the sale of its medical devices and therapies directly to healthcare providers, hospitals, and clinics, with transactions occurring in a B2B model. The company is targeting expansion into new markets, particularly in Europe and Asia, with a strategic goal to enter these regions by the end of 2025. This growth strategy aligns with Glaukos' commitment to addressing the needs of ophthalmic disease management and improving patient outcomes globally.
Who invested in Glaukos
9 investors across 5 rounds
See all investors in Glaukos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Glaukos
Who invested in Glaukos?
Glaukos has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Glaukos raised?
Glaukos has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Glaukos last raise money?
Glaukos's most recent round on record is a Series F, in Jan 2013.
What does Glaukos do?
Glaukos Corporation is a specialized company that develops innovative therapies for ophthalmic diseases.
Where is Glaukos headquartered?
Glaukos is headquartered in Laguna Hills, US.
Which VCs invest in companies like Glaukos?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Glaukos's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series F
Raising like Glaukos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.